Impact of steroid use and glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy

•Preoperative steroids did not increase the risk of postoperative complications in diabetic gynecologic oncology patients.•Patients who had postoperative complications were more likely to have an average postoperative blood glucose of ≥ 180 mg/dL 24 h after surgery. We aimed to assess the impact of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology reports 2024-04, Vol.52, p.101344-101344, Article 101344
Hauptverfasser: Kincaid, Kaitlyn, Boitano, Teresa K.L., Scalise, Matthew, Patton, Samantha, Leath, Charles A., Straughn, John M., Smith, Haller J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Preoperative steroids did not increase the risk of postoperative complications in diabetic gynecologic oncology patients.•Patients who had postoperative complications were more likely to have an average postoperative blood glucose of ≥ 180 mg/dL 24 h after surgery. We aimed to assess the impact of preoperative steroid administration and perioperative glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy. This retrospective cohort study included gynecologic oncology patients with Type I and Type II diabetes (DM) undergoing laparotomy for any gynecologic indication at a single academic center from 10/2017 to 09/2020. The primary outcome was the rate of postoperative complications. Preoperative steroid administration and 24-hour postoperative average serum blood glucose (BG) ≥ 180 mg/dL were the studied exposures. Data was analyzed with SPSS Statistics v.28. 225 patients met inclusion criteria; 47.6 % had postoperative complications. Patient demographics were similar between patients with and without postoperative complications. Patients with complications had higher BMIs (36.8 vs. 34.0; p = 0.03), bowel surgery (33.0 % vs. 17.1 %; p = 0.008), operative time ≥ 240 min (14.2 % vs. 5.1 %; p = 0.02) and average BG ≥ 180 (63.6 % vs. 40.2 %; p 
ISSN:2352-5789
2352-5789
DOI:10.1016/j.gore.2024.101344